Benfooxythiamine is a transketolase (TKT) inhibitor. Benfooxythiamine inhibits SARS-CoV-2 replication and increases the activity of the glycolysis inhibitor 2DG. Benfooxythiamine has antiviral activit[1].
References
[1] Bojkova D, et al. Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy. Metabolites. 2021 Oct 13;11(10):699. DOI:10.3390/metabo11100699
